Contineum Therapeutics Publishes Discovery of Potential Best-in-Class LPAR1 Antagonist PIPE-791 in Journal of Medicinal Chemistry

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/1/2026

1. AMZN
2. RBLX
3. AAPL
4. RDDT
5. COIN
6. NBIX
7. DXCM
8. GH
9. GDDY
10. WU

Go back to Contineum Therapeutics Publishes Discovery of Potential Best-in-Class LPAR1 Antagonist PIPE-791 in Journal of Medicinal Chemistry
(NASDAQ: CTNM) Delayed: 15.49 -0.26 (1.65%)
Previous Close $15.75    52 Week High $ 
Open $15.75    52 Week Low $ 
Day High $16.08    P/E N/A 
Day Low $14.13    EPS $ 
Volume 449,576